市场调查报告书
商品编码
1370366
生物晶片市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球生物晶片市场规模达169亿美元。展望未来,IMARC集团预计到2028年市场规模将达到406亿美元,2023-2028年复合年增长率(CAGR)为15.8%。慢性病的盛行率不断上升、对个人化药物的偏好不断增加以及对早期检测癌细胞的需求不断增加是推动市场发展的一些关键因素。
生物晶片是指一种微型医疗设备,旨在在更短的时间内同时执行多个生化反应。它们包含排列在固体基质表面上的一组微测试位点或微阵列。它们以脱氧核糖核酸 (DNA)、蛋白质、酵素和晶片实验室的形式被广泛使用。它们结构紧凑、功能强大、快速、易于使用,并且能够准确地提供关键见解。它们非常适合储存个人医疗和财务讯息,并且可以轻鬆追踪人类或动物。它们被植入体内,协助监测、分析和控制患者的健康状况和体内的生物过程。除此之外,它们还有助于识别潜在危险、确保安全的环境和改善决策。因此,生物晶片在全球个体中的基因、肿瘤学、发炎诊断和分子分析中得到了应用。
目前,糖尿病、血压和慢性阻塞性肺病(COPD)等慢性病盛行率不断上升,是支持全球市场成长的关键因素之一。除此之外,生物晶片在基因组学、蛋白质组学和分子诊断领域的日益普及正在对市场产生积极影响。此外,生物晶片提供的各种好处,例如减少时间和金钱以及无需重型仪器即可提供高通量的能力,正在促进市场的成长。除此之外,全球医疗保健产业对省时且高品质设备的需求不断增加。再加上人们越来越偏好个人化药物和下一代定序(NGS)来治疗个体中的多种疾病,正在推动市场的成长。除此之外,越来越多地采用生物晶片来早期检测体内癌细胞,这为产业投资者提供了利润丰厚的成长机会。此外,老年人口的不断增加,以及世界各地对用于药物开发和发现的生物晶片的需求不断增长,正在提供良好的市场前景。此外,基于微流体的设备的生物医学进步和晶片实验室的创新在传染病的初步诊断中提供快速结果正在推动市场的成长。
The global biochips market size reached US$ 16.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.8% during 2023-2028. The growing prevalence of chronic diseases, increasing preferences for personalized medicines, and rising need for early detection of cancerous cells represent some of the key factors driving the market.
Biochips refer to a miniaturized medical device that is designed to perform several biochemical reactions simultaneously in less time. They comprise a collection of micro-test sites or microarrays, which are arranged on the surface of a solid substrate. They are widely available as deoxyribonucleic acid (DNA), protein, enzyme, and lab-on-a-chip. They are compact, powerful, fast, easy to use, and provide critical insights accurately. They are highly suitable for storing personal medical and financial information and can easily trace human beings or animals. They are implanted in the body and assist in monitoring, analyzing, and controlling the health of a patient and biological processes in the body. Besides this, they aid in identifying potential hazards, ensuring a safe environment, and improving decision-making. As a result, biochips find applications for gene, oncology, and inflammatory diagnosis and molecular analysis among individuals across the globe.
At present, rising prevalence of chronic diseases, such as diabetes, blood pressure, and chronic obstructive pulmonary disease (COPD), represents one of the key factors supporting the growth of the market around the world. Besides this, the growing utilization of biochips in genomics, proteomics, and molecular diagnostics among the masses is positively influencing the market. Additionally, various benefits offered by biochips, such as reduction of time and money and the ability to provide high throughput without any requirement of heavy instruments, is contributing to the growth of the market. Apart from this, there is a rise in demand for time-saving and high-quality devices in the healthcare industry across the globe. This, coupled with the increasing preference for personalized medicines and next-generation sequencing (NGS) to treat numerous diseases among individuals, is propelling the growth of the market. In addition to this, the rising adoption of biochips for early detection of cancerous cells in the body is offering lucrative growth opportunities to industry investors. Moreover, the increasing geriatric population, along with the growing demand for biochips for drug development and discovery around the world, is offering a favorable market outlook. Furthermore, the biomedical advancement in microfluidic-based devices and innovation in lab-on-a-chip to offer quick results at initial diagnosis of infectious disease is impelling the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global biochips market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, fabrication technique, analysis method, application and end user.
DNA Chip
Protein Chip
Lab-On-a-Chip
Enzyme Chip
The report has provided a detailed breakup and analysis of the biochips market based on the product type. This includes DNA chip, protein chip, lab-on-a-chip, and enzyme chip. According to the report, DNA chip represented the largest segment.
Microarray
Microfluidic
A detailed breakup and analysis of the biochips market based on the fabrication technique has also been provided in the report. This includes microarray and microfluidic. According to the report, microarray accounted for the largest market share.
Electrophoresis
Luminescence
Mass Spectrometry
Electrical Signals
Magnetism
A detailed breakup and analysis of the biochips market based on the analysis method has also been provided in the report. This includes electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism. According to the report, electrophoresis accounted for the largest market share.
Molecular Analysis
Hybridization
Protein
Immunological
Biomolecules
Biomarker
Others
Diagnosis
Gene Diagnosis
Oncology
Inflammatory
Others
Non-Biological Usage
A detailed breakup and analysis of the biochips market based on the application has also been provided in the report. This includes molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory, and others), and non-biological usage. According to the report, diagnosis (gene diagnosis, oncology, inflammatory, and others) accounted for the largest market share.
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostics Centers
Academic and Research Institutes
Others
A detailed breakup and analysis of the biochips market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Spain
Russia
Italy
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Others
Latin America
Mexico
Brazil
Argentina
Others
Middle East and Africa
Turkey
Saudi Arabia
United Arab Emirates
Others
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for biochips. Some of the factors driving the North America biochips market included the growing prevalence of lifestyle diseases, rising geriatric population, presence of several biotechnology companies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global biochips market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Thermo Fisher Scientific, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.